Published in Health Risk Factor Week, July 17th, 2007
Study 1: Scientists discuss in "Plasma concentrations of osteoprotegerin during normo- and hyperglycaemic clamping" new findings in diabetes. "Plasma levels of osteoprotegerin (OPG) are elevated in subjects with diabetes as well as in non-diabetic subjects with cardiovascular disease. In previous studies a positive correlation was found between plasma levels of OPG and markers of glycaemic control in diabetic subjects," scientists in Aarhus, Denmark report.
"The aim of the present study was to examine the effect of acute hyperglycaemia on plasma levels of OPG in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.